Impact of Prostate Cancer Screening on Behavior Modifications and Racial Disparities
Specific Aim 1: To determine if additional benefits of prostate cancer screening by secondarily affecting all overall mortality by creating more opportunities to engage patients and intervene earlier in other disease processes.
Hypothesis 1: Overall and Cardiovascular mortality is reduced in the screening arm of the PLCO trial as compared to the usual care arm. (sub-analysis in race)
Specific Aim 2: To determine the incidence and impact of smoking on mortality and if it is reduced in the screening arm that could be directly or indirectly influenced by visiting the physician more regularly in the screening arm.
Hypothesis 2: Smoking is cessation is more common and relapse is less common in the supplemental questionnaire in the screening arm compared to the usual care arm and improves overall, cardiovascular, and prostate specific mortality. (sub-analysis in race)
Specific Aim 3: To determine the incidence and impact of exercise on mortality outcomes and if exercise is effected by prostate cancer screening.
Hypothesis 3: Exercise with confirmatory reduction in body mass index is more common in the screening arm compared to the usual care arm and improves overall, cardiovascular, and prostate specific mortality. (sub-analysis in race)
Ian M. Thompson MD UTHSCSA
Robin Leach Ph.D. UTHSCSA
Donna Ankerst Ph.D. UTHSCSA
-
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials.
Gelfond JA, Hernandez B, Goros M, Ibrahim JG, Chen MH, Sun W, Leach RJ, Kattan MW, Thompson IM, Ankerst DP, Liss M
BMC Urol. 2022 Mar 26; Volume 22 (Issue 1): Pages 45 PUBMED